Back to Search Start Over

Video: Hugin Sees Celgene Revlimid Patents Holding Until 2027

Source :
Bloomberg Television Video Content. Oct 28, 2010
Publication Year :
2010

Abstract

Oct. 28 (Bloomberg) -- Robert Hugin, chief executive officer of Celgene Corp., talks about possible generic competition for Celgene's best-selling Revlimid cancer pill. Hugin also discusses Celgene's drug pipeline and [...]

Subjects

Subjects :
Celgene Corp. -- Intellectual property
Bloomberg Television -- Intellectual property
Pharmaceutical industry -- Intellectual property
Cable television broadcasting industry -- Intellectual property
Video recordings
Patents
Patent/copyright issue
General interest
Revlimid (Medication)

Details

Language :
English
Database :
Gale General OneFile
Journal :
Bloomberg Television Video Content
Publication Type :
Video Recording
Accession number :
edsgcl.240730222

Tools

Authors Abstract Subjects Details